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ABSTRACT Studies of rapid (N-type) inactivation induced by different synthetic inactivating peptides in several voltage-
dependent cation channels have concluded that the channel inactivation "entrance" (or "receptor" site for the inactivating
peptide) consists of a hydrophobic vestibule within the internal mouth of the channel, separated from the cytoplasm by a
region with a negative surface potential. These protein domains are conformed from alternative sequences in the different
channels and thus are relatively unrestricted in terms of primary structure. We are reporting here on the interaction between
the inactivating peptide of the Shaker B K+ channel (ShB peptide) or the noninactivating ShB-L7E mutant with anionic
phospholipid vesicles, a model target that, as the channel's inactivation "entrance," contains a hydrophobic domain (the
vesicle bilayer) separated from the aqueous media by a negatively charged vesicle surface. When challenged by the anionic
phospholipid vesicles, the inactivating ShB peptide 1) binds to the vesicle surface with a relatively high affinity, 2) readily
adopts a strongly hydrogen-bonded P-structure, likely an intramolecular P "hairpin," and 3) becomes inserted into the
hydrophobic bilayer by its folded N-terminal portion, leaving its positively charged C-terminal end exposed to the extrave-
sicular aqueous medium. Similar experiments carried out with the noninactivating, L7E-ShB mutant peptide show that this
peptide 1) binds also to the anionic vesicles, although with a lower affinity than does the ShB peptide, 2) adopts only
occasionally the characteristic ,B-structure, and 3) has completely lost the ability to traverse the anionic interphase at the
vesicle surface and to insert into the hydrophobic vesicle bilayer. Because the negatively charged surface and the hydro-
phobic domains in the model target may partly imitate those conformed at the inactivation "entrance" of the channel proteins,
we propose that channel inactivation likely includes molecular events similar to those observed in the interaction of the ShB
peptide with the phospholipid vesicles, i.e., binding of the peptide to the region of negative surface potential, folding of the
bound peptide as a ,B-structure, and its insertion into the channel's hydrophobic vestibule. Likewise, we relate the lack of
channel inactivation seen with the mutant ShB-L7E peptide to the lack of ability shown by this peptide to cross through the
anionic interphase and insert into the hydrophobic domains of the model vesicle target.
INTRODUCTION
Fast (or N-type) inactivation exhibited by many voltage-
dependent ion channels specific for Na+ or K+ implies the
physical occlusion of the channel's internal mouth by a
flexible cytoplasmic domain of the channel protein itself,
which acts as an open channel blocker (the "ball and chain"
hypothesis of channel inactivation; Armstrong and Beza-
nilla, 1977). Studies in the Shaker B (ShB) potassium chan-
nel (Hoshi et al., 1990; Zagotta et al., 1990) have demon-
strated that the inactivating "ball" peptide (ShB peptide)
corresponds to the first 20 amino acids in the N-terminal
region of each ShB channel subunit (H2N-MAAVAG-
LYGLGEDRQHRKKQ). Indeed, addition into the intracel-
lular media of free, synthetic ShB peptide restores fast
inactivation in mutant ShB channels that do not inactivate
because of deletions in their N-terminal region, suggesting
that the synthetic peptide contains all of the necessary
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molecular determinants to recognize the channel protein and
carry out its inactivating function (Zagotta et al., 1990).
Moreover, the ability of the ShB peptide to induce inacti-
vation has been found to depend on certain features of its
primary structure (Murrell-Lagnado and Aldrich, 1993). For
instance, substitution of a single nonpolar residue in the
hydrophobic stretch in the N-terminal region of the ShB
peptide by either positively or negatively charged amino
acids, such as that in the ShB-L7E peptide (mutant of the
ShB peptide in which the leucine 7 in the wild peptide is
substituted by glutamate), results in the loss of the ability of
the peptide to induce channel inactivation.
Additional studies using synthetic peptides and different
voltage-dependent channels have suggested that the sites on
the channels for binding of the inactivating peptides consist
of a hydrophobic protein pocket, which becomes accessible
only upon channel opening, separated from the cytoplasm
by a region with a negative surface potential (Jan and Jan,
1992; Catterall, 1995; Kukuljan et al., 1995). In the ShB K+
channel in particular, it has been proposed that the region of
negative surface potential is made up of a ring of glutamate
residues plus the negatively charged ends of the S4-5 helix
dipoles contributed by each channel subunit (Jan and Jan,
1992; Durell and Guy, 1992). Similarly, the formation of the
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internal hydrophobic protein vestibule has been attributed to
the rotation of the amphipathic S4_5 helices induced by
channel activation (Durell and Guy, 1992). Regardless of
whether such components of the channel inactivation "en-
trance" are correctly assigned, it is remarkable to observe
that the ShB-inactivating peptide induces inactivation not
only in the ShB channel, but also in a variety of other
voltage-dependent K+ channels (Zagotta et al., 1990;
Isacoff et al., 1991; Dubinsky et al., 1992), high conduc-
tance Ca2+-activated K+ channels (Toro et al., 1992; Foster
et al., 1992), or cyclic nucleotide-gated channels (Kramer et
al., 1994), some of which do not normally inactivate. Fur-
thermore, the presumed inactivating peptide from the volt-
age-dependent Na+ channel serves also as an inactivation
peptide for the ShB K+ channel (Patton et al., 1993). From
these observations of "crossed inactivation" and from the
diversity in primary structure of the molecules involved, it
follows that rather than highly specific amino acid se-
quences, the interaction between the inactivating peptide
and the channel "entrance" is likely to imply the mutual
recognition of domains conformed from alternative se-
quences in each of the channel proteins or the inactivating
peptides showing crossed inactivation with foreign partners.
In this manuscript we have studied the interaction be-
tween the K+ channel-inactivating ShB peptide or its non-
inactivating ShB-L7E mutant with anionic phospholipid
vesicles, a model target that, as the channel's inactivation
"entrance," contains a region with a negative surface poten-
tial (the negatively charged vesicle surface) and a hydro-
phobic domain (the lipid bilayer). Our expectations are that
by exploring in detail the interaction of the synthetic pep-
tides with such a model target, we might be able to infer
similar molecular events involved in the inactivation of the
real channel and understand the molecular basis of how a
single amino acid substitution in the sequence of the inac-
tivating peptide, such as that in the L7E mutant, determines
a loss of function. A previous report using this approach
(Fernandez-Ballester et al., 1995) showed that the anionic
phospholipid vesicles induce the adoption of distinct con-
formations by the synthetic ShB and ShB-L7E peptides.
Whereas the mutant peptide remained in a nonordered con-
formation under most of the experimental conditions ex-
plored, the inactivating ShB peptide readily adopted a
highly stable structure. Although the conformation adopted
by the ShB peptide when it binds to the channel protein
remains unknown, the proposal of a (3-structure as the
"active" conformation seems consistent with inferences
made from electrophysiological recordings (Murrell-
Lagnado and Aldrich, 1993), which predict an "extended"
conformation for the channel-bound ShB peptide during
inactivation. Additionally, it has been found that certain
conditions known to make the ShB peptide unable to pro-
duce channel inactivation, such as trypsin hydrolysis, also
prevent the peptide from interacting with the model anionic
vesicle target (Fernandez-Ballester et al., 1995), thus pro-
viding further support for the hypothesis that the negatively
model target could partly imitate some of the features of the
inactivation "entrance" in the channel protein.
MATERIALS AND METHODS
Deuterium oxide (D20, 99.9% by atom) was purchased from Sigma. The
phospholipids phosphatidylcholine (PC), phosphatidylglycerol (PG), and
phosphatidic acid (PA) (Avanti Polar Lipids) were all derivatives of egg
yolk PC and therefore had the same fatty acid composition. The synthetic
1,2-sn-dimyristoyl phospholipids 1,2-dimyristoyl-sn-glycero-3-phospho-
choline (DMPC), 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol (DMPG),
and 1,2-dimyristoyl-sn-glycero-3-phosphate (DMPA) were also from
Avanti Polar Lipids. All phospholipids were dissolved in chloroform and
divided into aliquots, and the solvent was driven off under a stream of
nitrogen and under vacuum.
Peptide synthesis and characterization
The peptides ShB (MAAVAGLYGLGEDRQHRKKQ) and ShB-L7E
(MAAVAGEYGLGEDRQHRKKQ) were synthesized as C-terminal
amides on an automatic multiple synthesizer (AMS 422; Abimed) using a
solid-phase procedure and standard (9-fluorenyl methoxy carbonyl) chem-
istry (Fernandez-Ballester et al., 1995). The peptides were purified by
reverse-phase high-performance liquid chromatography to better than 95%
purity, and their composition and molecular weight were confirmed by
amino acid analysis and mass spectrometry, respectively (Fernandez-Ball-
ester et al., 1995). Residual trifluoroacetic acid used both in the peptide
synthesis and in the high-performance liquid chromatography mobile phase
(the trifluoroacetate ion has a strong infrared absorbance around 1670
cm', which interferes with the characterization of the amide I band;
Surewicz et al., 1993) was removed by submitting the peptides to several
lyophilization-solubilization cycles in 10 mM HCI (Zhang et al., 1992).
The lyophilized peptides were divided into aliquots and kept frozen until
use.
Fluorescent labeling of
cysteine-containing peptides
The peptides ShB-21C (MAAVAGLYGLGEDRQHRKKQC) and ShB-
L7E-21C (MAAVAGEYGLGEDRQHRKKQC) were synthesized as C-
terminal amides as described above for the ShB and ShB-L7E peptides.
These cysteine-containing peptides at their C-terminal ends were fluores-
cently labeled by alkylation with NBD-iodoacetamide (N,N'-dimethyl-N-
(iodoacetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine) (Mo-
lecular Probes, Eugene, OR). Briefly, lyophilized aliquots containing 1-3
mg of either cysteine-peptide were dissolved in 0.6 ml of 0.5 M Tris buffer,
pH 8.5, reacted during 1 h and in the dark with a fourfold molar excess of
the reducing agent dithiothreitol and alkylated by the addition of an excess
of the NBD-iodoacetamide (2.5-fold molar excess over the dithiothreitol
used in each experiment) previously dissolved in dimethyl sulfoxide. The
reaction mixtures were incubated for 1 h in the dark and under an inert
atmosphere, then subjected to chromatography in a Biogel P-2 (Fine)
column (1.5 X 15 cm), with 0.05 M acetic acid as the eluant. The resulting
NBD-labeled peptides eluted in the void volume and were subsequently
lyophilized, rechromatographed in the Biogel P-2 column, divided into
aliquots, lyophilized again, and kept frozen until further use. Peptide
concentration in these samples was determined by amino acid analysis. The
extent of peptide derivatization estimated by the carboxymethylcysteine/
peptide molar ratios was better than 97%. Either the cysteine-containing
ShB-21C and ShB-L7E-21C peptides, or their NBD derivatives, exhibited
conformations similar to those of the ShB and ShB-L7E peptides, respec-
charged and the hydrophobic domains in the anionic vesicle
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Fluorescence assay of peptide binding
Small unilamellar vesicles were used in these studies to minimize light-
scattering phenomena. The lyophilized lipids (PC, PG, or PA) were resus-
pended in the appropriate buffers to give final concentrations of 0.05, 0.5,
and 5 mM (in terms of lipid phosphorus), kept at 50°C for 90 min,
frequently vortexed, and then sonicated in a bath-type sonicator until the
samples became completely transparent. Small aliquots from these stock
vesicle solutions were added in triplicate to 1 .5-ml aliquots from a 0.1 .M
solution of NBD-labeled peptides at 25°C. Fluorescence intensity was
measured immediately afterward as a function of the lipid:peptide molar
ratio in a SLM 8000 spectrofluorometer with the excitation and emission
wavelengths set at 470 and 530 nm, respectively. To account for the
background (scattering) signal contributed by the lipids to the emitted
fluorescence, the readings observed when titrating identical concentrations
of unlabeled peptides with the same lipid vesicles were subtracted from
each recording of fluorescence intensity. The binding isotherms were
analyzed as partition equilibria (Peled and Shai, 1993), according to the
expression Xb* = Kp* Cf, where Xb* is the molar ratio of bound peptide per
60% of the total lipid (i.e., assuming that the peptides were initially
partitioned only over the outer leaflet of the membrane), Kp* is the partition
coefficient, and Cf represents the concentration of free (unbound) peptide
at equilibrium. Foo, the fluorescence signal obtained when all of the peptide
is lipid-bound, was extrapolated from a double reciprocal plot of F, the
observed fluorescence intensity, versus the total concentration of lipid.
Knowing F and Foo, as well as Fo (the fluorescence exhibited by the free,
unbound peptide), the fraction of membrane-bound peptide (4b) can be
calculated by using the expression fb = (F - FO)/(F<,. - Fo). Once the fb
values for each of the experimental points in the binding curves are known,
Cf and Xb* can be easily calculated. Finally, the partition coefficient Kp* is
determined by extrapolating the initial slope in a Xb* versus Cf plot to zero
Cf values.
Differential scanning calorimetry
To facilitate the comparison with reported calorimetric data on lipid phase
transitions, large multilamellar vesicles made from synthetic DMPA,
DMPG, or DMPC were used in these studies. Dried lipid films were
suspended in the required buffer, depending on the desired pH and com-
position (see figure legends for details), to give a final concentration of 2
mM in terms of lipid phosphorus. The suspended lipids were kept for 90
min above their phase transition temperatures and vortexed. The resulting
liposomes were stored overnight, at 4°C, to ensure a complete hydration of
the sample before the differential scanning calorimetry (DSC) experiments.
Thermograms were recorded on a high-resolution Microcal MC-2 dif-
ferential scanning microcalorimeter, equipped with the DA-2 digital inter-
face and data acquisition utility for automatic data collection, as described
earlier (Villar et al., 1988). The lipid dispersions containing added ShB or
ShB-L7E peptides at different molar ratios, and the corresponding buffer in
the reference cell, were thermally equilibrated in the microcalorimeter, at
10°C for 45 min, before heat was applied. Differences in the heat
capacity between the sample and the reference cell were obtained by
raising the temperature at a constant rate of 45°C/h. Transition tempera-
tures and enthalpies were calculated by fitting the observed transitions to a
single van't Hoff component. Reported transition temperatures correspond
to those at which there is a maximum differential heat capacity, as observed
in the thermograms.
Infrared measurements
For amide I band recordings, lyophilized aliquots of the synthetic peptides
and the desired lipids were separately hydrated in 25 ,u1 of D20 buffers (see
figure legends for details on the composition of the buffers) to avoid the
interference of H20 infrared absorbance (1645 cm-'; Mendelsohn and
Mantsch, 1986). In the hydration of the phospholipid samples, either
sonication of the samples in a bath-type sonicator or forcing the suspen-
sions several times in and out of a micropipette tip was used, with identical
spectral results. The resulting solutions were mixed by placing them
together in a liquid demountable cell (Harrick, Ossining, NY) equipped
with CaF2 windows and 50-,m-thick mylar spacers, and maintained at
room temperature for -30 min to ensure that the isotopic H-D amide
proton exchange reached equilibrium, as judged by a constant minimum
absorbance at the residual amide II band in the peptide's infrared spectra.
The peptide concentrations in the final mixtures usually ranged from 0.9 to
3.6 mM, whereas the phospholipids were mostly used at -26 mM, thus
resulting in phospholipid-to-peptide molar ratios ranging from 7 to 29.
For the acquisition of the 950-1500 cm- 1 spectral region comprising the
absorbance bands assigned to vibrations of the phosphoryl group of PA,
ZnS windows were used in the spectrometer cell and the samples were
prepared essentially as described above, but using an aqueous buffer (10
mM sodium acetate, 10 mM 3-(N-morpholino)propanesulfonic acid, 10
mM 3-[cyclohexylamino]-l-propanesulfonic acid, 100 mM NaCl, 0.1 mM
EDTA, and 0.01% NaN3) adjusted to a pH ranging from 5.5 to 10.5
(Bhushan and McNamee, 1993). The usual peptide and PA concentrations
used in these experiments were 14 and 58 mM, respectively.
Fourier-transform infrared spectroscopy (FTIR) spectra were taken in a
Nicolet 520 instrument equipped with a DTGS detector, as previously
described (Castresana et al., 1992), using 200 spectral scans to define the
amide I band and 600 scans to define the absorbance bands arising from the
phosphoryl group of PA. Given the good resolution of component bands
observed in the original spectra, no resolution-enhancement techniques
(Fourier derivation or deconvolution; Moffatt and Mantsch, 1992) were
applied to the spectral data.
RESULTS
Binding of peptides to phospholipid vesicles
To study the binding of the synthesized peptides to the
different phospholipid membranes, the peptides were selec-
tively labeled by alkylation with NBD-iodoacetamide of the
sulfhydryl group of a cysteine residue added at the C-
terminal end of the ShB and ShB-L7E peptides. Labeling of
the peptides with the environmentally sensitive NBD probe,
the fluorescence of which increases greatly and shifts to
shorter wavelengths when in a hydrophobic media, provides
a highly reliable and sensitive method that has been used to
study the binding of a variety of different peptides to phos-
pholipid vesicles (see Peled and Shai, 1993, and references
therein).
To evaluate peptide binding, aliquots of NBD-labeled
peptides were mixed with increasing amounts of small
unilamellar phospholipid vesicles, and the resulting in-
creases in the fluorescence intensity were plotted versus the
phospholipid:peptide molar ratio to generate binding curves
(Fig. 1). The analysis of the binding data was carried out as
described by Peled and Shai (1993) (see Materials and
Methods) to determine the surface partition coefficient
(Kp*), assuming that the peptides initially partitioned only
over the outer leaflet of the different phospholipid vesicles
(Table 1). At pH 7.0, neither the ShB nor the ShB-L7E
peptide binds significantly to PC vesicles. On the other
hand, both peptides bind quite efficiently and in a saturable
manner to PA and, to a lesser extent, to PG vesicles. The
Kp* values observed under our experimental conditions for
binding of the ShB peptide to either PA or PG vesicles
(-8 X 105 and -0.3 X 105 M-1, respectively) are higher
or comparable to those reported for binding to zwitterionic
1315Encinar et al.
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FIGURE 1 Representative changes in the fluorescence emitted by 0.1
,uM solutions of NBD-labeled ShB (A) or ShB-L7E (B) peptides, upon
titration with PC (U, El), PG (A, A), and PA (-, 0) vesicles at the
indicated phospholipid/peptide molar ratios. (C) Examples ofXb* versus Cf
plots (see Materials and Methods) for several of the samples included in A
and B, used to determine the partition coefficients (Kp*) given in Table 1.
The buffer used in these experiments was 10 mM HEPES, pH 7.0,
containing 100 mM NaCI.
phospholipid vesicles of 1) peptides resembling transmem-
brane protein segments, 2) various signal peptides, or 3)
membrane-permeating bioactive peptides known to form
stable structures within membranes (see Peled and Shai,
1993, and references therein). Kp* values obtained for the
mutant ShB-L7E peptide and either PA or PG vesicles were
always much lower than those corresponding to the ShB
peptide under identical experimental conditions.
The position of the fluorescence emission maxima exhib-
ited by the NBD-labeled peptides upon binding to the phos-
pholipid vesicles also provides information on the relative
location within the vesicles of the peptides' C-termini, at
which the environmentally sensitive NBD moiety is bound.
Both the NBD-labeled ShB and the ShB-L7E peptides in
solution exhibit emission maxima at 554-555 nm, which
reflect a hydrophilic environment for the NBD moiety (Ra-
jarathnam et al., 1989). Similar emission maxima are also
exhibited by the labeled peptides in the presence of PC
vesicles (Table 1). However, binding of the peptides to
either PA or PG vesicles determines a blue shift in the
fluorescence emission maxima, which indicates a relocation
of the NBD group to a more hydrophobic environment
(Table 1). The extent of the observed blue shift for both
peptides (531-533 nm and 531-534 nm in PA and PG
vesicles, respectively) also suggests that penetration of the
C-termini of the peptides into the hydrophobic bilayer pro-
vided by the anionic phospholipid is not as deep as that
reported for pore-forming polypeptides (emission maxima
518-526 nm; Rapaport and Shai, 1992; Gazit and Shai,
1993), and it rather resembles that observed for an NBD
group located at or near the membrane surface (emission
maxima of 530-534 nm; Chattopadhyay and London, 1987;
Rajarathnam et al., 1989; Pouny et al., 1992).
The interaction of unlabeled ShB and ShB-L7E peptides
with the anionic PA vesicles can also be assessed by mon-
itoring the infrared absorbance bands at 1180 and 980 cm-1
arising from different stretching vibrations of the monoan-
ionic and dianionic forms, respectively, of the PA phospho-
ryl group (Sanchez-Ruiz and Martinez-Carrion, 1986;
Bhushan and McNamee, 1993). Monitoring of the pH de-
pendence of the above infrared bands in plain PA vesicles,
exactly as described by Bhushan and McNamee (1993),
makes it possible to calculate a pKa of -8.0 corresponding
to the deprotonation of the monoanionic phosphoryl group
to produce the dianionic form (data not shown). The pres-
ence of either ShB or ShB-L7E peptides in these samples
does not interfere with the spectral region of interest, which
shows the same 1180 and 980 cm-' bands observed in the
plain PA samples, and therefore, these bands were also used
to estimate the pKa for the deprotonation of the peptide-
bound phosphoryl group. For the ShB peptide/PA vesicle
samples, the pKa shift to -7.4 at the peptide-to-lipid ratio
used in these experiments. This indicates that the ShB
peptide stabilizes the dianionic form of PA, thus suggesting
that the phospholipid phosphoryl group is clearly involved
in the binding of the ShB peptide. On the other hand, the
shift in the pKa observed in the presence of ShB-L7E is not
-c
1316 Biophysical Journal
2 [
1
Inactivating Peptide of the Shaker B K+ Channel
TABLE I Fluorescence emission maxima (Amax) and surface partitioning constants (k1p) exhibited by NBD-labeled peptides in
the presence of phospholipid vesicles
Amax (nm) K X 10-4 (M-l)
Peptide
designation pH Buffer PC PA PG PC PA PG
ShB-NBD 7 555 551 531 531 No binding 77.1 (± 11.6) 2.80 (±1.10)
ShBL7E-NBD 7 554 551 533 534 No binding 3.05 (±1.45) 0.72 (+0.20)
ShB-NBD 8.5 552 530 536 1.95 (+0.65) 0.64 (0.09)
ShBL7E-NBD 8.5 553 536 552 0.62 (±0.025) >0.05
as large as that produced by the ShB peptide (pKa -7.7),
which seems consistent with the experiments using fluores-
cently labeled peptides in which the surface partition coef-
ficients estimated for the interaction of the ShB peptide with
PA vesicles were always higher than those corresponding to
the ShB-L7E peptide.
Differential scanning calorimetric studies of
peptide insertion into lipid bilayers
The possible implication of the hydrophobic domains of the
phospholipid bilayers in the association of the peptides with
the vesicles was investigated by DSC using synthetic
dimirystoyl derivatives of the different phospholipids,
which have convenient phase transition temperatures at
23.50C, 23.30C, and 49.6°C for DMPC, DMPG, and
DMPA, respectively. In these experiments, peptide inser-
tion into the lipid bilayer and, therefore, its interaction with
the phospholipid acyl chains are expected to prevent part of
the phospholipid molecules from undergoing the phase tran-
sition characteristic of the "pure" phospholipid species and
thus decrease the phase transition enthalpy in a peptide
concentration-dependent manner (Papahadjopoulos et al.,
1975). We observed that neither the ShB nor the ShB-L7E
peptides cause any effects on the transition temperature or
the transition enthalpy of DMPC vesicles (data not shown).
On the other hand, confronting the ShB peptide to anionic
phospholipid vesicles (Fig. 2, A and B) causes a large,
concentration-dependent decrease in the transition enthalpy,
which is slightly more pronounced in DMPG than in DMPA
vesicles, without modifying the phase transition tempera-
ture. A plot of the observed changes in the transition en-
thalpies versus the peptide/phospholipid molar ratios used
in these studies (Fig. 2 C) predicts that each ShB peptide
molecule prevents an average of three to four anionic phos-
pholipid molecules from undergoing the phase transition.
As for the mutant ShB-L7E peptide, its effects on the
DMPA or DMPG phase transition enthalpies are negligible
compared to those of the ShB peptide (Fig. 2, A and B).
DMPG vesicles were also used to study whether the
observed peptide insertion into the phospholipid bilayer is
pH-dependent. DMPG was chosen for these studies because
it lacks chemical groups whose titration within the pH
region of interest could interfere with the peptide insertion
phenomena determined by DSC. Fig. 3 shows that, indeed,
the ability of the ShB peptide to insert into the hydrophobic
domains of the anionic bilayer is strongly pH-dependent. A
maximum decrease in the DMPG phase transition enthalpy
in the presence of the ShB peptide can be observed at pH
6.0, whereas increasing the pH to 8.5 or beyond renders the
ShB peptide incapable of inserting into the phospholipid
bilayer. In spite of the observed lack of peptide insertion
under the latter conditions, peptide binding experiments,
carried out at pH 8.5 using NBD-labeled peptides as de-
scribed above, demonstrate that the ShB peptide still binds
to anionic phospholipid vesicles, although with a much
lower affinity (Table 1). As for the mutant ShB-L7E pep-
tide, its effects on the DMPG phase transition enthalpies are
negligible at all of the pHs explored (Fig. 3).
Fourier transform infrared spectroscopy studies
of peptide conformation
Fig. 4 shows the infrared amide I region of the spectra
corresponding to the ShB and ShB-L7E peptides in the
presence of different phospholipid vesicles. Either peptide
in the presence of PC vesicles (Fig. 4, A and B) (as well as
in plain buffers in the absence of lipids) exhibits a bell-
shaped amide I band with a maximum centered at 1645
cm- characteristic of nonordered protein structures. The
similarities observed between the spectra of the peptides in
solution and in the presence of PC vesicles is consistent
with the lack of binding of either peptide to the zwitterionic
PC vesicles. On the other hand, the spectra of the ShB
peptide in the presence of either PA or PG vesicles exhibit
a very prominent amide I component at 1623 cm- 1 and a
smaller one at 1689 cm-1 (lower traces in Fig. 4, C and E),
which have been related to the adoption of a strongly
hydrogen-bonded structure (Demel et al., 1990). Such a
1623 cm-1 component in the ShB spectra appears readily
and has approximately the same relative importance regard-
less of the peptide concentration or the peptide-to-phospho-
lipid molar ratio used in the FTIR experiments (ranging
from 1.2 to 10 mg/ml and from 2 to 60 (by mole), respec-
tively; Fernandez-Ballester et al., 1995). Even though they
are similar, the ShB spectra taken in the presence of PG or
PA vesicles differ in that the characteristic 1623 cm-l
component is more heat-stable in the former, because at
temperatures as high as 70°C, the absorbance at 1623 cm-'
seen in the ShB/PG samples is still maintained at no less
than 65% of that observed at room temperature, whereas
that seen in the presence of PA vesicles decreases more
1317Encinar et al.
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FIGURE 2 Changes in the gel to liquid crystal phase transition enthalpies of
DMPA (A, 0, *) or DMPG (B, A, A) large multilamellar vesicles in the
presence of increasing concentrations of either ShB (-, A) or ShB-L7E (0, A)
peptides, as determined by differential scanning calorimetry of the indicated
phospholipid/peptide mixtures in 10 mM HEPES, pH 7.0, 100 mM NaCl.
Error bars are within the size of the symbols used to plot the experimental
results. In the absence of added peptides, the estimated phase transition
enthalpies in vesicles made from pure DMPA or DMPG were 5.4 and 6.5
kcailmol of phospholipid, respectively. (C) Plot of the observed AH/AHO from
above (transition enthalpies of either DMPA (0) or DMPG (A) detenrined in
the presence (Al) and in the absence (AHO) of added ShB peptide) versus the
ShB peptide/phospholipid ratios. In spite of the heterogeneity arising from the
use of data from DMPA and DMPG samples altogether, a linear extrapolation
of such plot indicates that the addition of ShB peptide in this sample at a
peptide/phospholipid ratio of -0.3 will completely avoid the occurrence of the
cooperative lipid phase transition.
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FIGURE 3 pH dependence of the observed gel to liquid crystal phase
transition enthalpy of large multilamellar DMPG vesicles, as determined
by differential scanning calorimetry. Symbols correspond to DMPG vesi-
cles alone (0) and in the presence of either ShB (A) or ShB-L7E (A)
peptides, both at a peptide/DMPG molar ratio of 0.1. The buffers used at
each of the indicated pHs were: pH 5.0, 25 mM citrate, 50 mM phosphate,
20 mM NaCl, 130 mM KCl; pH 6.0, 10 mM 2-(N-morpholino)ethanesul-
fonic acid, 20 mM NaCl, 130 mM KCl; pH 7.0, 10 mM phosphate, 20 mM
NaCl, 130 mM KCI; pH 7.5, 10 mM phosphate, 20 mM NaCl, 130 mM
KCl; pH 8.0, 10 mM N-(2-hydroxyethyl) piperazine-N'-3-propanesulfonic
acid Epps, 20 mM NaCl, 130 mM KCI; pH 8.5, 10 mM Epps, 20 mM
NaCl, 130 mM KCl.
markedly with increasing temperature (Fig. 4, C and E,
middle traces). Other properties attesting to a remarkable
conformational stability exhibited by the ShB peptide in the
presence of anionic phospholipid vesicles are that the ab-
sorbance at 1623 cm-' 1) recovers quite efficiently upon
cooling of previously heat-denatured samples (Fig. 4, C and
E, upper traces); 2) is fairly insensitive to increasing the
ionic strength of the aqueous media, unless the vesicles are
preincubated, before the addition of the peptide, with NaCl
at more than 1 M, which efficiently prevents the conforma-
tional event; 3) is insensitive to the presence of low con-
centrations of nonanionic detergents such as octyl-glu-
coside, unless the vesicles are completely disrupted by the
detergents at concentrations above their critical micellar
concentration; and 4) is insensitive to the presence of mil-
limolar concentrations of EDTA (data not shown).
As for the mutant ShB-L7E peptide (Fig. 4, D and F), the
1623 cm-1 structural component can be observed only in
PG vesicles (Fig. 4 F), at a moderately high peptide con-
centration and only in the virtual absence of EDTA (below
-20 ,uM), and even then it is much less heat-stable than the
component seen in the ShB peptide under similar conditions
Al
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ShB
A)
PC
ShBL7E
B)
tra arises from peptide bound to the anionic phospholipid
vesicles.
Because adoption of the J3 structure at 1623 cm-1 by the
SliB peptide occurs in the presence of anionic phospholipid
vesicles but not in PC vesicles, additional experiments were
done in the presence of vesicles made from mixtures of
natural anionic phospholipids and PC to determine the min-
imum amounts of PA or PG required to induce such a
structure. Fig. 5, A and C, shows that the appearance of the
1623 cm-' component in the ShB spectra requires a simi-
larly high percentage (--50%) of either PA or PG in the
PA
ShB
pH=7.0 pH=8.5
PG
1700 1650 1600 1700 1650 1600
Wavenumber, cm -1
FIGURE 4 Infrared amide I band region of the original spectra of the
ShB (A, C, and E) and the ShB-L7E (B, D, and F) peptides in the presence
of PC (A and B), PA (C and D), and PG (E and F) vesicles. The samples
were suspended in a D20 medium prepared from 10 mM HEPES buffer,
pH 7.4, containing 130 mM KCl and 20mM NaCi. The final concentration
of either peptide in all the samples was -4 mM, and the phospholipid
concentrations ranged from 32 to 35 mM, depending upon the different
phospholipids. In this figure, as well as in Fig. 5, the spectra of the different
buffers alone were subtracted from those of the peptide-containing sam-
ples. The triplet of traces shown in C, D, E, and F correspond to spectra of
samples taken at 20'C (lower traces in each triplet), spectra taken in
samples heated at 70'C (middle traces. "heat-denatured" samples). and
spectra of the heated samples after recooling to 20'C (upper traces,
"renatured" samples).
(Fig. 4 F, middle trace) and recovers very poorly from heat
denaturation (Fig. 4 F, upper trace).
It should be noted that, based on the binding experiments
using the fluorescence peptides described above, it is ex-
pected that at the peptide-to-lipid ratios used commonly in
the FTIR measurements, only a portion of the added peptide
is lipid-bound, and thus the observed peptide amide I bands
shown in Fig. 4 should be the result of contributions from
both lipid-bound and lipid-free peptide. In this respect, we
found that the spectra taken from pellets obtained by ultra-
centrifugation of the peptide-lipid incubation mixtures, in
which most or all of the peptide present is lipid-bound, have
an even more conspicuous 1623 cm-1 component (data not
shown). These observations further emphasize that the ap-
pearance of the 1623 cm-1 component in the infrared spec-
ShBL7E
100%
90%
50%
30%
PA/PC
PG/PC
PA/PC
PG/PC
1700 1650 1600 1700 1650
Wavenumber, cm -1
1600
FIGURE 5 Infrared amide I band region of the original spectra of the
ShB (A-D) and the ShB-L7E (E-H) peptides in the presence of phospho-
lipid vesicles made from PA/PC (A, B, E, and F) or PG/PC (C, D, G, and
H) mixtures. The spectra in the left column (A, C, E, and G) have been
taken in a D20 media prepared from 10 mM HEPES buffer, pH 7.4,
containing 130mM KCI and 20mM NaCl, and in those in the right column
(B, D, F, and H) the D20 media was prepared from 10 mM Epps buffer,
pH 8.5, containing 130 mM KCI and 20 mM NaCl. The stacks of spectra
shown in each panel correspond to different samples in which the percent-
age of the acidic phospholipid (either PA or PG) in the acidic phospho-
lipids/PC mixtures used to make the vesicles were 30%, 50%, 90%, or
100% (from the lower to the upper trace in each stack, respectively). To
avoid an excessive complication of the figure, such percentages have been
indicated only in B as an example. The peptide and phospholipid concen-
trations in these samples were approximately as in those in Fig. 4.
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anionic phospholipids/PC mixed vesicles. Similar experi-
ments were conducted at pH 8.5 (the pKa for the deproto-
nation of the monoanionic PA is -8) to investigate the
possible role of an increased surface charge of the vesicles
in the observed phenomena. At pH 8.5, most of the PA
molecules should be in the dianionic form, thus providing a
net negative charge at the surface of the PA/PC vesicles
considerably higher than that found in the PG/PC vesicles.
Under these conditions, the 1623 cm-' component in the
ShB spectra becomes noticeable at lower percentages of PA
in the PA/PC mixed vesicles (Fig. 5 B), despite the fact that
at this pH, at which some of the basic groups (most likely,
the amino-terminal group and possibly the lysine side
chains clustered near the C-terminus) in the peptide should
be mostly deprotonated, the absorbance of the peptide at
1623 cm-1 in the PG/PC vesicles decreases slightly (comn-
parison between Fig. 5, C and D).
As for the behavior of the ShB-L7E mutant peptide (Fig.
5, E-H), it is observed that the 1623 cm-1 component
appears only in the PG/PC vesicles and at a very high
percentage of PG (Fig. 5 G). Furthermore, increasing the pH
to 8.5 causes a complete disappearance of such spectral
components (Fig. S H).
Lipid phase separation studies
Additional DSC experiments were performed using vesicles
made from mixtures of DMPA and DMPC to explore
whether the presence of the ShB peptide in such vesicles
induces lipid phase separation. DMPC and the monoanionic
form of DMPA exhibit an ideal mixing at pH 6.0 (Fig. 6),
which, depending on the proportion of the two phospholip-
ids used in the mixtures, produces a wide endotherm with a
transition temperature intermediate to those corresponding
to the pure phospholipid components. The addition of ShB
peptide to such mixtures, at a fairly high peptide-to-phos-
pholipid ratio (see legend to Fig. 6), reduces the enthalpy of
the wide transition to -70% of the initial value but does not
promote the appearance of additional endotherms such as
those characteristic of the pure phospholipid components, as
would have been expected if segregation of lipid domains
had occurred.
DISCUSSION
Interaction of the ShB and ShB-L7E peptides with
the model anionic vesicle target
Binding studies using NBD-labeled peptides show that pep-
tide binding to zwitterionic phospholipid vesicles does not
occur, but there is peptide binding to vesicles made from
anionic phospholipids. The electrostatic component of this
binding process is evidenced by 1) the effects observed by
FTIR on the stabilization of the dianionic phosphoryl group
ofPA by the presence of either peptide, and 2) the decreased
binding observed upon increasing the pH to -8.5, which is
likely to cause partial deprotonation of both the amino
I I I I I I
0
0
0
_4
0
0
C)
cl
,>4
A\
___-- b~a
~.X\_b
>_~~C
_\-. d
I I I I I I J
0 10 20 30 40 50 60
Temperature (0C)
FIGURE 6 Effects of the addition of ShB peptide on the ideal lipid
mixing exhibited by DMPA and DMPC at pH 6.0. For the experiment
shown in the figure, large multilamellar vesicles were made from a DMPA:
DMPC mixture (60:40, by mole) in 50 mM 2-(N-morpholino)ethanesulfo-
nic acid buffer, pH 6.0, containing 100 mM NaCl, 1 mM EDTA. Differ-
ential scanning calorimetry thermograms are shown for such mixed
vesicles at a concentration of 2 mM in terms of total phospholipids, in the
absence (scan b) and in the presence (scan c) of added ShB peptide at a 0.1
peptide/phospholipid molar ratio. Traces a and d represent thermograms
corresponding to pure DMPA and DMPC vesicles, respectively.
terminal group and the Lys side chains at the peptide C-
terminal ends and thus reduce electrostatic interaction with
the negatively charged vesicle surface. Quantitative differ-
ences observed in the binding of either ShB or ShB-L7E
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peptide to vesicles made from either PA or PG indicate that
1) the binding of the ShB peptide derivative is much tighter
than that seen with the ShB-L7E labeled peptide, and 2) the
binding of either fluorescent peptide to PA vesicles occurs
with higher affinity than to PG vesicles. On a purely elec-
trostatic basis, the former could be explained by the pres-
ence of the additional net negative charge consequence of
the L7E substitution in the mutant peptide, whereas the
latter should be expected to arise from the above-mentioned
peptide-induced stabilization of dianionic lipid species,
which can occur only in the PA vesicles.
When challenged by anionic lipid vesicles, the native
ShB peptide undergoes a dramatic structural change, from
the predominantly nonordered conformation exhibited in
solution or in the presence of zwitterionic lipid vesicles, to
a strongly hydrogen-bonded 1B-structure characterized by a
prominent spectral component at 1623 cm -. Such an
adopted conformation does not result from peptide aggre-
gation, because the absorbance at 1623 cm-' is not depen-
dent upon the peptide concentration or the lipid-to-peptide
ratios used in these studies (Fernandez-Ballester et al.,
1995). Furthermore, the 1623 cm-' 13-structure component
present in these samples exhibits a great stability to drastic
changes in the experimental conditions, including heating at
high temperatures, large changes in ionic strength or pH,
and the addition of detergents or EDTA. On the other hand,
cleavage of residues 15 to 20 by hydrolysis with trypsin was
found to impede the adoption by the ShB 1-14 peptide of
the characteristic 13-structure seen in the whole ShB peptide
(Fernandez-Ballester et al., 1995), suggesting that the an-
choring of the cationic C-terminal portion of the peptide to
the negatively charged vesicle surface plays an important
role in determining the final conformation. The overall
conclusion from the above observations is that the intact
ShB peptide, when challenged by the anionic vesicle tar-
gets, has a remarkable tendency to rapidly adopt a highly
stable 13-structure. This, however, has certain requirements
that must be satisfied. For instance, the experiments using
vesicles made from anionic phospholipids/PC mixtures
show that such an adoption of 13-structure by the ShB
peptide requires that the vesicle target has a relatively high
density of negative charges on the vesicle surface (high
percentage of anionic phospholipids in the mixed vesicles).
In fact, the proportion of anionic phospholipids to PC in the
mixed vesicles must be maintained above 50% to allow the
adoption of 13-structure by the peptide. Such a proportion
could only be lowered when using PA/PC mixtures at
alkaline pH, at which dianionic PA species are present.
Second, based on the lack of peptide-induced lipid phase
separation observed by DSC, it is concluded that such an
adequate negatively charged vesicle surface has to preexist
as an organized structure before peptide addition, because
the ShB peptide appears unable to reorganize its own mi-
croenvironment upon interaction with the phospholipid
membrane.
In contrast to the observations made with the native ShB
vesicles adopts 13-structure in a much more restrictive man-
ner, i.e., at high peptide concentrations and only in the
presence of PG vesicles, and at pH values below 8 and in the
absence of EDTA, and even when such structure is finally
adopted it is quite heat-unstable.
The ability of the peptides to insert into the hydrophobic
vesicle bilayer is probably what distinguishes best between
the ShB and ShB-L7E peptides in their interaction with the
anionic vesicle targets. Thus, the mutant ShB-L7E peptide,
even under conditions leading to the adoption of 13-struc-
ture, does not insert into the vesicle bilayer. On the other
hand, the native ShB peptide inserts quite efficiently in
either DMPG or DMPA vesicles, causing a concentration-
dependent decrease in the enthalpy of the lipid phase tran-
sition, while leaving the phase transition temperature unal-
tered. This behavior is entirely similar to that described by
Papahadjopoulos et al. (1975) for the interaction of integral
membrane proteins with lipid bilayers. The insertion into
the bilayer, however, should not include the C-terminal
region of the ShB peptide, as suggested 1) by the value of
the emission maximum at 530-535 nm exhibited by the
NBD-labeled peptide bound to either PA or PG vesicles,
which indicates that rather than being embedded in the
bilayer, the NBD group covalently attached to the C-termi-
nus is located at or near the membrane surface, and 2) by the
fact that most of the potential trypsin cleavage sites in the
vesicle-inserted peptide remain accessible to polymer-im-
mobilized trypsin added to the extravesicular aqueous me-
dium (unpublished observation).
The study of the pH dependence of peptide insertion in
DMPG vesicles shows a maximum decrease in the enthalpy
of the lipid phase transition at pH 6, whereas increasing the
pH to near 8.5, at which the ShB peptide is still perfectly
able to adopt the characteristic structure, prevents the
peptide from inserting into the phospholipid bilayer. This
demonstrates (along with the lack of insertion seen under all
experimental conditions with the mutant peptide) that adop-
tion of 13-structure may occur separately and does not nec-
essarily imply peptide insertion into the bilayer. In our
interpretation, the folding of the peptide caused by the
adoption of an intramolecular 13-structure by the N-terminal
half of the ShB peptide at neutral pH is likely to bring amino
acid residues of different signs closer together, thus favoring
the formation of salt bridges. For instance, this could be the
case for the positively charged amino terminal and the
negatively charged E12 or D13. This would certainly in-
crease the stability contributed by hydrogen bonding to the
overall structure, but perhaps more importantly, it would
have an effect of "net charge cancellation," which is ex-
pected to make the folded N-terminal half of the peptide
capable of 1) traversing the anionic interphase formed by
the phospholipid polar headgroups and 2) partitioning into
the hydrophobic bilayer. According to this idea, the lack of
insertion of the ShB peptide seen at pH 8.5 should be
ascribed to an altered charge balance caused by deprotona-
tion of basic groups. Furthermore, it follows from this
peptide, the mutant ShB-L7E peptide bound to the anionic
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be able to insert into the bilayer because the net negative
charge from the E7 substitution can not be canceled out,
regardless of whether the mutant peptide adopts (-structure.
The latter receives further support from the observation that
mutants of the ShB channel in which the L7 residue was
substituted by either glutamate or lysine residues (in which
either a negatively or a positively charged group, respec-
tively, could not be canceled out) do not show inactivation
(Hoshi et al., 1990).
Predicted behavior of the inactivating peptide
during channel inactivation
The observation of "crossed inactivation" between chan-
nel proteins and inactivating peptides of different origins
(see the Introduction) suggests that channel inactivation
occurs as a consequence of the interaction between com-
plementary domains, relatively unrestricted in terms of
their primary structure, contained in the two interacting
molecules. These observations make it conceivable that
indeed the interaction of the inactivating peptide with the
model vesicle target, which also contains an anionic
surface and a hydrophobic region, could imitate some-
what the interaction occurring during the association of
the peptide with the corresponding domains in the inac-
tivation "entrance" of the real channel protein. This as-
sumption does not mean that the relatively simple struc-
tural elements in the model system exactly mimic those
more complex elements configuring the peptide receptor
site in the real channel protein. However, we believe that
based on the behavior exhibited by the ShB peptide in our
simple model target, several predictions can be reason-
ably made as to the molecular events that might occur
during channel inactivation. First, according to the model
proposed by Durell and Guy (1992), it could be assumed
that the organized protein region with a negative surface
potential that becomes exposed to the intracellular me-
dium upon channel opening indeed provides a site with a
sufficiently high density of negatively charged groups for
binding of the ShB peptide, as seen with the surface of
the anionic vesicles. This, in turn, should immediately
determine the folding of the peptide from the nonordered
conformation exhibited in solution into an intramolecular
(3-sheet "hairpin" structure that, having an adequate
charge balance, should readily insert into the hydropho-
bic vestibule within the channel protein. According to
this proposal, the channel would remain inactivated as
long as the peptide (3-hairpin remains inserted and would
reactivate upon peptide withdrawal, which seems consis-
tent with the idea that channels reopen during recovery
from inactivation (Demo and Yellen, 1991; Ruppersberg
et al., 1991). The above proposal also seems consistent
with observations made from electrophysiological re-
cordings, which indicate that electrostatic interaction of
the peptide with the anionic site on the channel protein
determines primarily the "on" rate (the rate of onset of
inactivation), whereas hydrophobic interactions deter-
mine the unblocking or "off' rate (Murrell-Lagnado and
Aldrich, 1993; Toro et al., 1994).
It should be noted here that we considered it unlikely that
the cytoplasmic leaflet of the plasma membrane would act
as an alternative target for the peptide "in vivo," precisely
because natural membranes do not contain sufficient an-
ionic phospholipids (and the peptide seems unable to draw
them together around it) to provide the high density of
negative charges needed for the interaction with the peptide.
As for the mutant ShB-L7E peptide, which should also be
expected to bind to the anionic site although with a lower
affinity, its lack of capacity to induce channel inactivation
could perhaps be explained by the practical impossibility
that its N-terminal portion, carrying a net negative charge,
would traverse the anionic interphase and insert into the
hydrophobic domain of the channel protein. Finally, the
known effect of trypsin of preventing channel inactivation
by the ShB peptide could be tentatively explained by the
loss of the positively charged groups present at the peptide's
C-terminal end produced upon trypsin cleavage, which, by
preventing the peptide from anchoring to the anionic site in
the channel "entrance," leaves no chance that the peptide
folding and insertion steps will occur.
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